http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/ News About Tech, Money and Innovation Tue, 24 Nov 2009 05:47:06 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/comment-page-1/#comment-556488 VentureBeat » Big Pharma’s personalized-medicine consortium: Is it for real? Fri, 28 Sep 2007 19:43:16 +0000 http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/#comment-556488 [...] that pose the biggest threat to the blockbuster-drug model in the first place, as discussed here. (Put briefly, a blockbuster drug by definition is taken by large numbers of people, for long [...] [...] that pose the biggest threat to the blockbuster-drug model in the first place, as discussed here. (Put briefly, a blockbuster drug by definition is taken by large numbers of people, for long [...]

]]> http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/comment-page-1/#comment-516420 VentureBeat » Biogenerics: The bad arguments just won’t stop Fri, 07 Sep 2007 02:49:20 +0000 http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/#comment-516420 [...] better than two decades, and at least until the industry hit its recent bad page (see our coverage here), they’ve coped with it just fine. Had that industry continued to innovate the way it’s [...] [...] better than two decades, and at least until the industry hit its recent bad page (see our coverage here), they’ve coped with it just fine. Had that industry continued to innovate the way it’s [...]

]]> http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/comment-page-1/#comment-516434 VentureBeat » Biogenerics: The bad arguments just won’t stop Fri, 07 Sep 2007 02:49:20 +0000 http://venturebeat.com/2007/08/09/is-big-pharma-down-for-the-count/#comment-516434 [...] better than two decades, and at least until the industry hit its recent bad page (see our coverage here), they’ve coped with it just fine. Had that industry continued to innovate the way it’s [...] [...] better than two decades, and at least until the industry hit its recent bad page (see our coverage here), they’ve coped with it just fine. Had that industry continued to innovate the way it’s [...]

]]>